際際滷

際際滷Share a Scribd company logo
Alzheimers Disease
By: Ryan Triplett
Alzheimers
 The deterioration of intellectual capabilities, memory,
judgment, and personality to the extent that daily
functioning and quality of life are seriously impaired.
 Generally occurs in the elderly impairing brain function,
which can lead to dementia.
 Named for German neurologist Alois Alzheimer in 1907.
Statistics
 4 million or more cases in U.S.
 100,000 die each year.
 4th major leading cause of
death in U.S.
 65 or older when symptoms
can begin
Clinical Features
 Loss of short-term memory and ability to create
memories
 Concentration on past
 Loss of time
 Communication diminishes
 Personality changes
 Delusions
 Become immobilized and uncomprehending
 Death due to respiratory failure
 65 and up disease lasts 8-20 years
 65 and down disease lasts 5-10 years disease more
rapid
Histological Analysis
3 distinctive neuropathological features
1. Devastating losses of synapses and neurons within
hippocampus and entorhinal cortex.
2. Dense spherical structures, called senile plaques (SP),
prevalent outside the neurons of the hippocampus and
other regions of the brain.
3. Aggregations of fibrils (Neurofibrillary tangles, NFT)
accumulate within cell bodies and dendritic processes
of the neurons of the hippocampus, neurocortex,
entorhinal cortex, and other brain parts.
Pictures of Brain Degradation
Degradation contd
Senile Plaques
 Densely packed fibrous
structures called amyloid
bodies.
 Consists of mainly
protein, 4-kDa peptide.
 Many isoforms make up
the amyloid proteins.
 Amyloid precursor protein
another source of which
can lead to AD.
Functional role unknown.
Neurofibrillary Tangles
 Consist of helical filaments called PHF.
 Intertwined protein strands made of tau protein
molecules.
 Formation of NFTs not unique to AD.
 Found in many other neurodegenerative disorders
with dementias, affecting the brain.
 Scientists believe that the amyloid proteins lead
to the formation of the neurofibrillary tangles,
and both can lead to AD symptoms.
Diagnosis
 Only definitive way is to use brain scans
(CT) to see plaques or tangles in brain
tissue.
 Tests used to exclude other diseases.
Treatments
 No treatment can prevent Alzheimers
 Drugs for early stages
 Cognax, Aricept, Exelon, or Razadyne
 Severe stages
 Memantine (Namenda)
 Medicines used to control symptoms,
allow caregivers to provide easier care.
Research
 Neuroimaging
 Finding damaged parts of the brain
 Alzheimers Genetics
 Anti-oxidants
 Ginkgo biloba
 Using to stimulate memory
 Estrogen
 Tested for levels found in AD patients, which
are women
References
 Pasternak, J. Jack. Introduction to Molecular Genetics.
2nd edition.2005. pg. 403-408.
 www.bic.ucs.edu/images/alz3d.jpg
 www.ahaf.org
 www.nia.nih.gov/Alzheimers/Publications

More Related Content

Similar to AlzheimersDisease-Ryantriplettnew.ppt (20)

ALZHIMER DISEASE ANKIT.pptx
ALZHIMER DISEASE ANKIT.pptxALZHIMER DISEASE ANKIT.pptx
ALZHIMER DISEASE ANKIT.pptx
AnkitKumar215277
Alzimers
AlzimersAlzimers
Alzimers
kv meg and centre
ibsbshsbabsnbound2375408123068793778.pptx
ibsbshsbabsnbound2375408123068793778.pptxibsbshsbabsnbound2375408123068793778.pptx
ibsbshsbabsnbound2375408123068793778.pptx
CarlaJaninePastorLib1
Alzheimer
AlzheimerAlzheimer
Alzheimer
University of the Punjab
dementia - organic disorders mental health nursing
dementia - organic disorders mental health nursingdementia - organic disorders mental health nursing
dementia - organic disorders mental health nursing
ssuserfbf2b11
ECE-2 Alzhiemer's Disease_250123_111633.pdf
ECE-2 Alzhiemer's Disease_250123_111633.pdfECE-2 Alzhiemer's Disease_250123_111633.pdf
ECE-2 Alzhiemer's Disease_250123_111633.pdf
prathamdwivedi3
Alzheimer's disease
Alzheimer's diseaseAlzheimer's disease
Alzheimer's disease
Sanil Varghese
Alzheimer's Disease and its pathophysiology
Alzheimer's Disease and its pathophysiologyAlzheimer's Disease and its pathophysiology
Alzheimer's Disease and its pathophysiology
Achyut Adhikari
Chapter 7 (revised)
Chapter 7 (revised)Chapter 7 (revised)
Chapter 7 (revised)
Vumile Mj Giovanni
Lesson 4 dementia and alzheimer's disease 2015
Lesson 4   dementia and alzheimer's disease 2015Lesson 4   dementia and alzheimer's disease 2015
Lesson 4 dementia and alzheimer's disease 2015
coburgpsych
Alzheimers presentation...........
Alzheimers presentation...........Alzheimers presentation...........
Alzheimers presentation...........
Muhammad Kamran
ppt on Alzheimers disease
ppt on Alzheimers disease ppt on Alzheimers disease
ppt on Alzheimers disease
Dr Ashok dhaka Bishnoi
Alzheimer's disease : Overview, Symptoms, Risk Factor, Causes, Treatment and ...
Alzheimer's disease : Overview, Symptoms, Risk Factor, Causes, Treatment and ...Alzheimer's disease : Overview, Symptoms, Risk Factor, Causes, Treatment and ...
Alzheimer's disease : Overview, Symptoms, Risk Factor, Causes, Treatment and ...
Lazoi Lifecare Private Limited
ALZHEIMER'S DEMENTIA anu_11034nhjjjjjjjjkk5.pptx
ALZHEIMER'S DEMENTIA anu_11034nhjjjjjjjjkk5.pptxALZHEIMER'S DEMENTIA anu_11034nhjjjjjjjjkk5.pptx
ALZHEIMER'S DEMENTIA anu_11034nhjjjjjjjjkk5.pptx
ShanuSoni7
Alzheimer's disease pharmacotherapy
Alzheimer's disease pharmacotherapyAlzheimer's disease pharmacotherapy
Alzheimer's disease pharmacotherapy
Koppala RVS Chaitanya
periventricular white watter disease. ppt.pptx
periventricular white watter disease. ppt.pptxperiventricular white watter disease. ppt.pptx
periventricular white watter disease. ppt.pptx
ssuserd2507a
Alzheimers disease 2
Alzheimers disease 2Alzheimers disease 2
Alzheimers disease 2
HARSHITA
Alzheimer s disease_powerpoint_skinner_kassandra
Alzheimer s disease_powerpoint_skinner_kassandraAlzheimer s disease_powerpoint_skinner_kassandra
Alzheimer s disease_powerpoint_skinner_kassandra
CMoondog
Tomser Ali Group No 22 AD.pptxAnxiety-Understanding-and-Managing-It.pptx
Tomser Ali Group No 22 AD.pptxAnxiety-Understanding-and-Managing-It.pptxTomser Ali Group No 22 AD.pptxAnxiety-Understanding-and-Managing-It.pptx
Tomser Ali Group No 22 AD.pptxAnxiety-Understanding-and-Managing-It.pptx
neestom1998
Alzheimer's disesae
Alzheimer's disesaeAlzheimer's disesae
Alzheimer's disesae
DrNidhiSharma4
ALZHIMER DISEASE ANKIT.pptx
ALZHIMER DISEASE ANKIT.pptxALZHIMER DISEASE ANKIT.pptx
ALZHIMER DISEASE ANKIT.pptx
AnkitKumar215277
ibsbshsbabsnbound2375408123068793778.pptx
ibsbshsbabsnbound2375408123068793778.pptxibsbshsbabsnbound2375408123068793778.pptx
ibsbshsbabsnbound2375408123068793778.pptx
CarlaJaninePastorLib1
dementia - organic disorders mental health nursing
dementia - organic disorders mental health nursingdementia - organic disorders mental health nursing
dementia - organic disorders mental health nursing
ssuserfbf2b11
ECE-2 Alzhiemer's Disease_250123_111633.pdf
ECE-2 Alzhiemer's Disease_250123_111633.pdfECE-2 Alzhiemer's Disease_250123_111633.pdf
ECE-2 Alzhiemer's Disease_250123_111633.pdf
prathamdwivedi3
Alzheimer's disease
Alzheimer's diseaseAlzheimer's disease
Alzheimer's disease
Sanil Varghese
Alzheimer's Disease and its pathophysiology
Alzheimer's Disease and its pathophysiologyAlzheimer's Disease and its pathophysiology
Alzheimer's Disease and its pathophysiology
Achyut Adhikari
Lesson 4 dementia and alzheimer's disease 2015
Lesson 4   dementia and alzheimer's disease 2015Lesson 4   dementia and alzheimer's disease 2015
Lesson 4 dementia and alzheimer's disease 2015
coburgpsych
Alzheimers presentation...........
Alzheimers presentation...........Alzheimers presentation...........
Alzheimers presentation...........
Muhammad Kamran
Alzheimer's disease : Overview, Symptoms, Risk Factor, Causes, Treatment and ...
Alzheimer's disease : Overview, Symptoms, Risk Factor, Causes, Treatment and ...Alzheimer's disease : Overview, Symptoms, Risk Factor, Causes, Treatment and ...
Alzheimer's disease : Overview, Symptoms, Risk Factor, Causes, Treatment and ...
Lazoi Lifecare Private Limited
ALZHEIMER'S DEMENTIA anu_11034nhjjjjjjjjkk5.pptx
ALZHEIMER'S DEMENTIA anu_11034nhjjjjjjjjkk5.pptxALZHEIMER'S DEMENTIA anu_11034nhjjjjjjjjkk5.pptx
ALZHEIMER'S DEMENTIA anu_11034nhjjjjjjjjkk5.pptx
ShanuSoni7
Alzheimer's disease pharmacotherapy
Alzheimer's disease pharmacotherapyAlzheimer's disease pharmacotherapy
Alzheimer's disease pharmacotherapy
Koppala RVS Chaitanya
periventricular white watter disease. ppt.pptx
periventricular white watter disease. ppt.pptxperiventricular white watter disease. ppt.pptx
periventricular white watter disease. ppt.pptx
ssuserd2507a
Alzheimers disease 2
Alzheimers disease 2Alzheimers disease 2
Alzheimers disease 2
HARSHITA
Alzheimer s disease_powerpoint_skinner_kassandra
Alzheimer s disease_powerpoint_skinner_kassandraAlzheimer s disease_powerpoint_skinner_kassandra
Alzheimer s disease_powerpoint_skinner_kassandra
CMoondog
Tomser Ali Group No 22 AD.pptxAnxiety-Understanding-and-Managing-It.pptx
Tomser Ali Group No 22 AD.pptxAnxiety-Understanding-and-Managing-It.pptxTomser Ali Group No 22 AD.pptxAnxiety-Understanding-and-Managing-It.pptx
Tomser Ali Group No 22 AD.pptxAnxiety-Understanding-and-Managing-It.pptx
neestom1998
Alzheimer's disesae
Alzheimer's disesaeAlzheimer's disesae
Alzheimer's disesae
DrNidhiSharma4

More from RisdaArba1 (11)

AKADEMIK DAN ORGANISASI.pptx
AKADEMIK DAN ORGANISASI.pptxAKADEMIK DAN ORGANISASI.pptx
AKADEMIK DAN ORGANISASI.pptx
RisdaArba1
PENYAKIT_DEGENERATIF.ppt
PENYAKIT_DEGENERATIF.pptPENYAKIT_DEGENERATIF.ppt
PENYAKIT_DEGENERATIF.ppt
RisdaArba1
biologyofageing-200410161806.pdf
biologyofageing-200410161806.pdfbiologyofageing-200410161806.pdf
biologyofageing-200410161806.pdf
RisdaArba1
thebiologyofageing-170828072832.pdf
thebiologyofageing-170828072832.pdfthebiologyofageing-170828072832.pdf
thebiologyofageing-170828072832.pdf
RisdaArba1
physiological_aging_changes.ppt
physiological_aging_changes.pptphysiological_aging_changes.ppt
physiological_aging_changes.ppt
RisdaArba1
maleandfemalebrain-whatconstitutesthegender-130731085427-phpapp02 (1).pptx
maleandfemalebrain-whatconstitutesthegender-130731085427-phpapp02 (1).pptxmaleandfemalebrain-whatconstitutesthegender-130731085427-phpapp02 (1).pptx
maleandfemalebrain-whatconstitutesthegender-130731085427-phpapp02 (1).pptx
RisdaArba1
010_ESI-ppt.ppt
010_ESI-ppt.ppt010_ESI-ppt.ppt
010_ESI-ppt.ppt
RisdaArba1
7_habits_1n (1).ppt
7_habits_1n (1).ppt7_habits_1n (1).ppt
7_habits_1n (1).ppt
RisdaArba1
7_habits_1n.ppt
7_habits_1n.ppt7_habits_1n.ppt
7_habits_1n.ppt
RisdaArba1
010_ESI-ppt (1).ppt
010_ESI-ppt (1).ppt010_ESI-ppt (1).ppt
010_ESI-ppt (1).ppt
RisdaArba1
animal-adaptations-2.ppt
animal-adaptations-2.pptanimal-adaptations-2.ppt
animal-adaptations-2.ppt
RisdaArba1
AKADEMIK DAN ORGANISASI.pptx
AKADEMIK DAN ORGANISASI.pptxAKADEMIK DAN ORGANISASI.pptx
AKADEMIK DAN ORGANISASI.pptx
RisdaArba1
PENYAKIT_DEGENERATIF.ppt
PENYAKIT_DEGENERATIF.pptPENYAKIT_DEGENERATIF.ppt
PENYAKIT_DEGENERATIF.ppt
RisdaArba1
biologyofageing-200410161806.pdf
biologyofageing-200410161806.pdfbiologyofageing-200410161806.pdf
biologyofageing-200410161806.pdf
RisdaArba1
thebiologyofageing-170828072832.pdf
thebiologyofageing-170828072832.pdfthebiologyofageing-170828072832.pdf
thebiologyofageing-170828072832.pdf
RisdaArba1
physiological_aging_changes.ppt
physiological_aging_changes.pptphysiological_aging_changes.ppt
physiological_aging_changes.ppt
RisdaArba1
maleandfemalebrain-whatconstitutesthegender-130731085427-phpapp02 (1).pptx
maleandfemalebrain-whatconstitutesthegender-130731085427-phpapp02 (1).pptxmaleandfemalebrain-whatconstitutesthegender-130731085427-phpapp02 (1).pptx
maleandfemalebrain-whatconstitutesthegender-130731085427-phpapp02 (1).pptx
RisdaArba1
010_ESI-ppt.ppt
010_ESI-ppt.ppt010_ESI-ppt.ppt
010_ESI-ppt.ppt
RisdaArba1
7_habits_1n (1).ppt
7_habits_1n (1).ppt7_habits_1n (1).ppt
7_habits_1n (1).ppt
RisdaArba1
7_habits_1n.ppt
7_habits_1n.ppt7_habits_1n.ppt
7_habits_1n.ppt
RisdaArba1
010_ESI-ppt (1).ppt
010_ESI-ppt (1).ppt010_ESI-ppt (1).ppt
010_ESI-ppt (1).ppt
RisdaArba1
animal-adaptations-2.ppt
animal-adaptations-2.pptanimal-adaptations-2.ppt
animal-adaptations-2.ppt
RisdaArba1

Recently uploaded (20)

RESEARCH PROBLEM, OBJECTIVES, OPERATIONAL DEFINITIONS
RESEARCH PROBLEM, OBJECTIVES, OPERATIONAL DEFINITIONSRESEARCH PROBLEM, OBJECTIVES, OPERATIONAL DEFINITIONS
RESEARCH PROBLEM, OBJECTIVES, OPERATIONAL DEFINITIONS
Shimla
Regulation of tubular reabsorption _AntiCopy.pdf
Regulation of tubular reabsorption _AntiCopy.pdfRegulation of tubular reabsorption _AntiCopy.pdf
Regulation of tubular reabsorption _AntiCopy.pdf
MedicoseAcademics
PULMONARY COMPLICATIONS IN CIRRHOSIS.pptx
PULMONARY COMPLICATIONS IN CIRRHOSIS.pptxPULMONARY COMPLICATIONS IN CIRRHOSIS.pptx
PULMONARY COMPLICATIONS IN CIRRHOSIS.pptx
arunmbbs7
Details Study of Haemorrhage Modern & Ayurveda
Details Study of Haemorrhage Modern & AyurvedaDetails Study of Haemorrhage Modern & Ayurveda
Details Study of Haemorrhage Modern & Ayurveda
RaviAnand201252
BIOMECHANICS OF THE MOVEMENT OF THE SHOULDER COMPLEX.pptx
BIOMECHANICS  OF THE MOVEMENT OF THE SHOULDER COMPLEX.pptxBIOMECHANICS  OF THE MOVEMENT OF THE SHOULDER COMPLEX.pptx
BIOMECHANICS OF THE MOVEMENT OF THE SHOULDER COMPLEX.pptx
drnidhimnd
DIAGNOSIS OF PREGNANCY PPT IN ALL TRIMESTER
DIAGNOSIS OF PREGNANCY PPT IN ALL TRIMESTERDIAGNOSIS OF PREGNANCY PPT IN ALL TRIMESTER
DIAGNOSIS OF PREGNANCY PPT IN ALL TRIMESTER
daminipatel37
PARIS SYSTEM FOR URINE CYTOLOGY paris system of reporting urine slidespptx
PARIS SYSTEM FOR URINE CYTOLOGY paris system of reporting urine slidespptxPARIS SYSTEM FOR URINE CYTOLOGY paris system of reporting urine slidespptx
PARIS SYSTEM FOR URINE CYTOLOGY paris system of reporting urine slidespptx
DrDivitasaxena1
Recent advances in GIST management in 2024
Recent advances in GIST management in 2024Recent advances in GIST management in 2024
Recent advances in GIST management in 2024
Sameer Rastogi
protocol-for-Hold-time-Study-of-Products
protocol-for-Hold-time-Study-of-Productsprotocol-for-Hold-time-Study-of-Products
protocol-for-Hold-time-Study-of-Products
alokksharma18
Non-Invasive ICP Monitoring for Neurosurgeons
Non-Invasive ICP Monitoring for NeurosurgeonsNon-Invasive ICP Monitoring for Neurosurgeons
Non-Invasive ICP Monitoring for Neurosurgeons
Dhaval Shukla
Module 3 Basic Life Support for the workplace
Module 3 Basic Life Support for the workplaceModule 3 Basic Life Support for the workplace
Module 3 Basic Life Support for the workplace
AbbieNunez
OBSTRUCTIVE JAUNDICE- Problem Oriented Approach.pptx
OBSTRUCTIVE JAUNDICE- Problem Oriented Approach.pptxOBSTRUCTIVE JAUNDICE- Problem Oriented Approach.pptx
OBSTRUCTIVE JAUNDICE- Problem Oriented Approach.pptx
Selvaraj Balasubramani
ALookInsideProvidenceResearchBiobanks.pdf
ALookInsideProvidenceResearchBiobanks.pdfALookInsideProvidenceResearchBiobanks.pdf
ALookInsideProvidenceResearchBiobanks.pdf
tiffanyecchang
Presentaci坦 "Projecte Benestar". MWC 2025
Presentaci坦 "Projecte Benestar". MWC 2025Presentaci坦 "Projecte Benestar". MWC 2025
Presentaci坦 "Projecte Benestar". MWC 2025
Badalona Serveis Assistencials
X-Ray-Generators-and-Transformers final.pdf
X-Ray-Generators-and-Transformers  final.pdfX-Ray-Generators-and-Transformers  final.pdf
X-Ray-Generators-and-Transformers final.pdf
Mohd Faraz
physiology 1 T3T4 & Jaundice & capillary circulation 愕悗悋.pptx
physiology 1 T3T4 & Jaundice & capillary circulation 愕悗悋.pptxphysiology 1 T3T4 & Jaundice & capillary circulation 愕悗悋.pptx
physiology 1 T3T4 & Jaundice & capillary circulation 愕悗悋.pptx
amralmohammady27
Pharm test bank- 12th lehne pharmacology nursing class
Pharm test bank- 12th lehne pharmacology nursing classPharm test bank- 12th lehne pharmacology nursing class
Pharm test bank- 12th lehne pharmacology nursing class
koxoyav221
Stability of Dosage Forms as per ICH Guidelines
Stability of Dosage Forms as per ICH GuidelinesStability of Dosage Forms as per ICH Guidelines
Stability of Dosage Forms as per ICH Guidelines
KHUSHAL CHAVAN
Hingula.ppt- Rasadravya parichaya- NCISM
Hingula.ppt- Rasadravya parichaya- NCISMHingula.ppt- Rasadravya parichaya- NCISM
Hingula.ppt- Rasadravya parichaya- NCISM
Shri Shivayogeeshwar Rural Ayurvedic Medical college, INCHAL,
HER2-Targeting Therapy in HER2+ MBC With and Without CNS Metastases: Selectio...
HER2-Targeting Therapy in HER2+ MBC With and Without CNS Metastases: Selectio...HER2-Targeting Therapy in HER2+ MBC With and Without CNS Metastases: Selectio...
HER2-Targeting Therapy in HER2+ MBC With and Without CNS Metastases: Selectio...
PVI, PeerView Institute for Medical Education
RESEARCH PROBLEM, OBJECTIVES, OPERATIONAL DEFINITIONS
RESEARCH PROBLEM, OBJECTIVES, OPERATIONAL DEFINITIONSRESEARCH PROBLEM, OBJECTIVES, OPERATIONAL DEFINITIONS
RESEARCH PROBLEM, OBJECTIVES, OPERATIONAL DEFINITIONS
Shimla
Regulation of tubular reabsorption _AntiCopy.pdf
Regulation of tubular reabsorption _AntiCopy.pdfRegulation of tubular reabsorption _AntiCopy.pdf
Regulation of tubular reabsorption _AntiCopy.pdf
MedicoseAcademics
PULMONARY COMPLICATIONS IN CIRRHOSIS.pptx
PULMONARY COMPLICATIONS IN CIRRHOSIS.pptxPULMONARY COMPLICATIONS IN CIRRHOSIS.pptx
PULMONARY COMPLICATIONS IN CIRRHOSIS.pptx
arunmbbs7
Details Study of Haemorrhage Modern & Ayurveda
Details Study of Haemorrhage Modern & AyurvedaDetails Study of Haemorrhage Modern & Ayurveda
Details Study of Haemorrhage Modern & Ayurveda
RaviAnand201252
BIOMECHANICS OF THE MOVEMENT OF THE SHOULDER COMPLEX.pptx
BIOMECHANICS  OF THE MOVEMENT OF THE SHOULDER COMPLEX.pptxBIOMECHANICS  OF THE MOVEMENT OF THE SHOULDER COMPLEX.pptx
BIOMECHANICS OF THE MOVEMENT OF THE SHOULDER COMPLEX.pptx
drnidhimnd
DIAGNOSIS OF PREGNANCY PPT IN ALL TRIMESTER
DIAGNOSIS OF PREGNANCY PPT IN ALL TRIMESTERDIAGNOSIS OF PREGNANCY PPT IN ALL TRIMESTER
DIAGNOSIS OF PREGNANCY PPT IN ALL TRIMESTER
daminipatel37
PARIS SYSTEM FOR URINE CYTOLOGY paris system of reporting urine slidespptx
PARIS SYSTEM FOR URINE CYTOLOGY paris system of reporting urine slidespptxPARIS SYSTEM FOR URINE CYTOLOGY paris system of reporting urine slidespptx
PARIS SYSTEM FOR URINE CYTOLOGY paris system of reporting urine slidespptx
DrDivitasaxena1
Recent advances in GIST management in 2024
Recent advances in GIST management in 2024Recent advances in GIST management in 2024
Recent advances in GIST management in 2024
Sameer Rastogi
protocol-for-Hold-time-Study-of-Products
protocol-for-Hold-time-Study-of-Productsprotocol-for-Hold-time-Study-of-Products
protocol-for-Hold-time-Study-of-Products
alokksharma18
Non-Invasive ICP Monitoring for Neurosurgeons
Non-Invasive ICP Monitoring for NeurosurgeonsNon-Invasive ICP Monitoring for Neurosurgeons
Non-Invasive ICP Monitoring for Neurosurgeons
Dhaval Shukla
Module 3 Basic Life Support for the workplace
Module 3 Basic Life Support for the workplaceModule 3 Basic Life Support for the workplace
Module 3 Basic Life Support for the workplace
AbbieNunez
OBSTRUCTIVE JAUNDICE- Problem Oriented Approach.pptx
OBSTRUCTIVE JAUNDICE- Problem Oriented Approach.pptxOBSTRUCTIVE JAUNDICE- Problem Oriented Approach.pptx
OBSTRUCTIVE JAUNDICE- Problem Oriented Approach.pptx
Selvaraj Balasubramani
ALookInsideProvidenceResearchBiobanks.pdf
ALookInsideProvidenceResearchBiobanks.pdfALookInsideProvidenceResearchBiobanks.pdf
ALookInsideProvidenceResearchBiobanks.pdf
tiffanyecchang
X-Ray-Generators-and-Transformers final.pdf
X-Ray-Generators-and-Transformers  final.pdfX-Ray-Generators-and-Transformers  final.pdf
X-Ray-Generators-and-Transformers final.pdf
Mohd Faraz
physiology 1 T3T4 & Jaundice & capillary circulation 愕悗悋.pptx
physiology 1 T3T4 & Jaundice & capillary circulation 愕悗悋.pptxphysiology 1 T3T4 & Jaundice & capillary circulation 愕悗悋.pptx
physiology 1 T3T4 & Jaundice & capillary circulation 愕悗悋.pptx
amralmohammady27
Pharm test bank- 12th lehne pharmacology nursing class
Pharm test bank- 12th lehne pharmacology nursing classPharm test bank- 12th lehne pharmacology nursing class
Pharm test bank- 12th lehne pharmacology nursing class
koxoyav221
Stability of Dosage Forms as per ICH Guidelines
Stability of Dosage Forms as per ICH GuidelinesStability of Dosage Forms as per ICH Guidelines
Stability of Dosage Forms as per ICH Guidelines
KHUSHAL CHAVAN

AlzheimersDisease-Ryantriplettnew.ppt

  • 2. Alzheimers The deterioration of intellectual capabilities, memory, judgment, and personality to the extent that daily functioning and quality of life are seriously impaired. Generally occurs in the elderly impairing brain function, which can lead to dementia. Named for German neurologist Alois Alzheimer in 1907.
  • 3. Statistics 4 million or more cases in U.S. 100,000 die each year. 4th major leading cause of death in U.S. 65 or older when symptoms can begin
  • 4. Clinical Features Loss of short-term memory and ability to create memories Concentration on past Loss of time Communication diminishes Personality changes Delusions Become immobilized and uncomprehending Death due to respiratory failure 65 and up disease lasts 8-20 years 65 and down disease lasts 5-10 years disease more rapid
  • 5. Histological Analysis 3 distinctive neuropathological features 1. Devastating losses of synapses and neurons within hippocampus and entorhinal cortex. 2. Dense spherical structures, called senile plaques (SP), prevalent outside the neurons of the hippocampus and other regions of the brain. 3. Aggregations of fibrils (Neurofibrillary tangles, NFT) accumulate within cell bodies and dendritic processes of the neurons of the hippocampus, neurocortex, entorhinal cortex, and other brain parts.
  • 6. Pictures of Brain Degradation
  • 8. Senile Plaques Densely packed fibrous structures called amyloid bodies. Consists of mainly protein, 4-kDa peptide. Many isoforms make up the amyloid proteins. Amyloid precursor protein another source of which can lead to AD. Functional role unknown.
  • 9. Neurofibrillary Tangles Consist of helical filaments called PHF. Intertwined protein strands made of tau protein molecules. Formation of NFTs not unique to AD. Found in many other neurodegenerative disorders with dementias, affecting the brain. Scientists believe that the amyloid proteins lead to the formation of the neurofibrillary tangles, and both can lead to AD symptoms.
  • 10. Diagnosis Only definitive way is to use brain scans (CT) to see plaques or tangles in brain tissue. Tests used to exclude other diseases.
  • 11. Treatments No treatment can prevent Alzheimers Drugs for early stages Cognax, Aricept, Exelon, or Razadyne Severe stages Memantine (Namenda) Medicines used to control symptoms, allow caregivers to provide easier care.
  • 12. Research Neuroimaging Finding damaged parts of the brain Alzheimers Genetics Anti-oxidants Ginkgo biloba Using to stimulate memory Estrogen Tested for levels found in AD patients, which are women
  • 13. References Pasternak, J. Jack. Introduction to Molecular Genetics. 2nd edition.2005. pg. 403-408. www.bic.ucs.edu/images/alz3d.jpg www.ahaf.org www.nia.nih.gov/Alzheimers/Publications